Cara Therapeutics SG&A Expense (TTM) Insights

Cara Therapeutics Inc (CARA)

0.305 +0.02 (+5.94%) USD | NASDAQ | Sep 27, 16:00

0.2976 -0.01 (-2.43%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2024	26.43M
March 31, 2024	27.57M
December 31, 2023	27.65M
September 30, 2023	27.50M
June 30, 2023	27.65M
March 31, 2023	27.68M
December 31, 2022	30.13M
September 30, 2022	35.21M
June 30, 2022	34.18M
March 31, 2022	32.27M
December 31, 2021	29.28M
September 30, 2021	24.43M
June 30, 2021	23.78M
March 31, 2021	23.55M
December 31, 2020	21.75M
September 30, 2020	19.72M
June 30, 2020	18.73M
March 31, 2020	18.31M
December 31, 2019	17.66M
September 30, 2019	17.75M
June 30, 2019	16.75M
March 31, 2019	15.45M

Date	Value
December 31, 2018	15.24M
September 30, 2018	13.52M
June 30, 2018	14.10M
March 31, 2018	13.09M
December 31, 2017	11.80M
September 30, 2017	10.84M
June 30, 2017	9.134M
March 31, 2017	8.886M
December 31, 2016	8.605M
September 30, 2016	8.623M
June 30, 2016	8.318M
March 31, 2016	7.746M
December 31, 2015	7.379M
September 30, 2015	7.044M
June 30, 2015	6.697M
March 31, 2015	6.246M
December 31, 2014	5.82M
September 30, 2014	4.855M
June 30, 2014	4.221M
March 31, 2014	3.872M
December 31, 2013	3.153M
September 30, 2013	2.795M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

17.66M

Minimum

Dec 2019

35.21M

Maximum

Sep 2022

25.56M

Average

26.96M

Median

SG&A Expense (TTM) Benchmarks